36139053|t|Changes in NMDA Receptor Function in Rapid Ischemic Tolerance: A Potential Role for Tri-Heteromeric NMDA Receptors.
36139053|a|In this study, we characterize biophysical changes in NMDA receptor function in response to brief non-injurious ischemic stress (ischemic preconditioning). Electrophysiological studies show NMDA receptor function is reduced following preconditioning in cultured rat cortical neurons. This functional change is not due to changes in the reversal potential of the receptor, but an increase in desensitization. We performed concentration-response analysis of NMDA-evoked currents, and demonstrate that preconditioned neurons show a reduced potency of NMDA to evoke currents, an increase in Mg2+ sensitivity, but no change in glycine sensitivity. Antagonists studies show a reduced inhibition of GluN2B antagonists that have an allosteric mode of action (ifenprodil and R-25-6981), but competitive antagonists at the GluR2A and 2B receptor (NVP-AMM077 and conantokin-G) appear to have similar potency to block currents. Biochemical studies show a reduction in membrane surface GluN2B subunits, and an increased co-immunoprecipitation of GluN2A with GluN2B subunits, suggestive of tri-heteromeric receptor formation. Finally, we show that blocking actin remodeling with jasplakinolide, a mechanism of rapid ischemic tolerance, prevents NMDA receptor functional changes and co-immunoprecipitation of GluN2A and 2B subunits. Together, this study shows that alterations in NMDA receptor function following preconditioning ischemia are associated with neuroprotection in rapid ischemic tolerance.
36139053	43	51	Ischemic	Disease	MESH:D002545
36139053	228	236	ischemic	Disease	MESH:D002545
36139053	245	253	ischemic	Disease	MESH:D002545
36139053	378	381	rat	Species	10116
36139053	572	576	NMDA	Chemical	MESH:D016202
36139053	664	668	NMDA	Chemical	MESH:D016202
36139053	703	707	Mg2+	Chemical	-
36139053	738	745	glycine	Chemical	MESH:D005998
36139053	808	814	GluN2B	Gene	24410
36139053	867	877	ifenprodil	Chemical	MESH:C010739
36139053	882	891	R-25-6981	Chemical	-
36139053	953	963	NVP-AMM077	Chemical	-
36139053	1089	1095	GluN2B	Gene	24410
36139053	1149	1155	GluN2A	Gene	24409
36139053	1161	1167	GluN2B	Gene	24410
36139053	1281	1295	jasplakinolide	Chemical	MESH:C057531
36139053	1318	1326	ischemic	Disease	MESH:D002545
36139053	1410	1423	GluN2A and 2B	Gene	24409;24410
36139053	1530	1538	ischemia	Disease	MESH:D007511
36139053	1584	1592	ischemic	Disease	MESH:D002545
36139053	Negative_Correlation	MESH:C010739	24410
36139053	Negative_Correlation	MESH:C057531	24409
36139053	Association	MESH:D002545	24409
36139053	Association	MESH:D002545	24410
36139053	Association	MESH:C057531	MESH:D002545
36139053	Negative_Correlation	MESH:C057531	24410

